Fact CheckerSign in

NCT00618553Active, not recruitingPhase 2

Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting

The Efficacy of Pulmonary Rehabilitation in Improving Surgical Eligibility for Lung Resection

Source: ClinicalTrials.gov · Last updated 16 Jul 2026

Brief summary (registry, in English)

The goal of this clinical research study is to see if pulmonary rehabilitation can improve patients' lung function, which would increase their chances of becoming eligible for surgery. The health of pulmonary rehabilitation participants after surgery will also be examined.

Status (registry)
Active, not recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
75 (estimated)
First submitted
28 Jan 2008
Start date
28 Jan 2008
Primary completion date
1 Sept 2028
Lead sponsor
M.D. Anderson Cancer Center
NCT number
NCT00618553

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 75
  • From 28 Jan 2008 to the primary completion date, 1 Sept 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previously reported severe pulmonary hypertension (pulmonary artery systolic pressure \> 60 as determined by echocardiogram), refractory cor pulmonale (as manifested by right ventricular dilatation or dysfunction by echocardiogram)
  • Previously reported exercise-induced syncope, angina, palpitation, arrhythmia, hypotension (drop of 20% of systolic/diastolic from baseline)

Other illness

  • Active psychiatric illness that could interfere with treatment.

Lab values

  • History of severe congestive heart failure (NYHA class 3 and 4) refractory to medical management, (LVEF \< 40% by echocardiogram).

Other

  • Bone metastasis

Who the study is looking for

  • Patients with anatomically resectable lung tumors who are deemed surgically inoperable based on preoperative pulmonary function testing FEV1 \< 80% pred; DLCO \< 80% pred; FEV1ppo \< 40% pred; DLCO ppo \< 40% pred AND VO2 peak \< 60% predicted or \< 15 ml/kg/min.
  • Patients deemed surgically inoperable based on poor performance status (ECOG score 2-3)
  • Any non-pulmonary co-morbidity must be stable according to institutional guidelines.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Texas - MD Anderson Cancer Center
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.